Ticagrelor Tablets 90Mg

Ticagrelor tablets are used to: Primary Uses: 1.⁠ ⁠Prevent blood clots in patients with acute coronary syndrome (ACS), myocardial infarction (heart attack), or stroke. 2.⁠ ⁠Reduce the risk of cardiovascular death, myocardial infarction, or stroke in patients with atherosclerosis. Secondary Uses: 1.⁠ ⁠Treat peripheral arterial disease (PAD). 2.⁠ ⁠Prevent blood clots in patients undergoing percutaneous coronary intervention (PCI). 3.⁠ ⁠Reduce the risk of cardiovascular events in patients with diabetes. Mechanism of Action: Ticagrelor is an antiplatelet medication that: 1.⁠ ⁠Inhibits platelet aggregation. 2.⁠ ⁠Blocks the P2Y12 receptor, preventing blood clots. Benefits: 1.⁠ ⁠Rapid onset of action. 2.⁠ ⁠Reduced risk of cardiovascular events. 3.⁠ ⁠Improved survival rates. 4.⁠ ⁠Reduced need for repeat revascularization procedures. Common Side Effects: 1.⁠ ⁠Bleeding (e.g., bruising, nosebleeds). 2.⁠ ⁠Dizziness. 3.⁠ ⁠Headache. 4.⁠ ⁠Nausea. 5.⁠ ⁠Fatigue. 6.⁠ ⁠Shortness of breath. Contraindications: 1.⁠ ⁠Active bleeding. 2.⁠ ⁠Severe liver impairment. 3.⁠ ⁠Pregnancy or breastfeeding. 4.⁠ ⁠Hypersensitivity to ticagrelor. Precautions: 1.⁠ ⁠Monitor bleeding risk. 2.⁠ ⁠Adjust dosage in patients with renal impairment. 3.⁠ ⁠Avoid concurrent use with strong CYP3A inhibitors. 4.⁠ ⁠Monitor for signs of liver damage. Dosage: •⁠ ⁠Initial dose: 180mg (loading dose). •⁠ ⁠Maintenance dose: 90mg twice daily. •⁠ ⁠Duration: Typically 12 months. Brand Names: •⁠ ⁠Brilinta (AstraZeneca) •⁠ ⁠Brilique (Europe) Patient Education: 1.⁠ ⁠Take medication as directed. 2.⁠ ⁠Monitor bleeding and report any unusual bleeding. 3.⁠ ⁠Follow a healthy lifestyle and diet. 4.⁠ ⁠Regularly check liver function and platelet count. Important Note: Consult your doctor or healthcare provider for personalized guidance on using ticagrelor tablets.